Mon, 14 Dec 2020 13:33:41 GMT
AstraZeneca shares drop on Alexion deal
On Monday, AstraZeneca's shares dropped 9% on the $39B worth deal for Alexion Pharmaceuticals, the US biotech company, marking the largest ever corporate acquisition of the British drugmaker.